Related by context. All words. (Click for frequent words.) 71 LungAlert TM 71 kidney urologic 70 FOLOTYN ® 70 Initiates Enrollment 69 Completes Patient Enrollment 69 Telik logo TELINTRA 69 SPL# Gel vaginal microbicide 69 liver resection surgeries 68 SIX RO ROG 68 MelaFind R 68 Files IND 68 include ColorectAlert TM 68 TRANSDUR ™ 68 Initiates Phase II 67 Receives Orphan Drug Designation 67 PROSTASCINT R 67 candidates Azedra TM 67 Oral Calcitonin 67 Personalized Immunotherapy 67 Awarded Qualifying Therapeutic 67 Announce License Agreement 67 Submits Biologics License Application 67 product platforms AZX# 67 JAK2 Inhibitor 67 Receives Approvable Letter 67 Crofelemer budesonide foam 67 Patient Enrollment 66 vapreotide acetate 66 Receives CE Marking 66 ELADUR ™ 66 Premarket Approval Application 66 Initiates Clinical Trial 66 Immunomedics Announces 66 Curaxin CBLC# 66 colorectal bladder 66 SoftScan ® 66 granted Ortec 66 pralatrexate injection folate analogue 66 HYVISC ® treatment 66 tiapamil 66 candidate CRLX# 66 ThermoDox ® clinical 66 Prochymal TM 66 personalized cellular immunotherapy 66 Granted Orphan Drug 66 Epeius Biotechnologies Corporation 66 successfully commercialize Iluvien 66 Submits Response 66 ALN TTR 66 intravesical infusion therapy 66 PANVAC VF 66 Completes Enrollment 65 candidate deforolimus 65 Oracea TM 65 AcryMed Incorporated 65 treat atrial flutter 65 Submits NDA 65 Combination REOLYSIN R 65 ARRY # 65 delivers fluocinolone acetonide FA 65 ALN HPN 65 TRANSDUR ® 65 Pivotal Clinical Trial 65 including eniluracil ADH 65 PCA3 test 65 XL# anticancer compounds 65 nasal calcitonin product 65 Prodarsan R 65 GVAX ® 65 Unigene nasal calcitonin 65 CYT# potent vascular disrupting 65 HE4 test 65 index assay IVDMIA 65 trastuzumab DM1 T DM1 65 Telatinib 65 By JENNIFER LEARN 65 Systemic Delivery 65 lexidronam injection 65 oral prodrug 65 Announces FDA Clearance 65 Reports Preclinical Data 65 Achieves Primary Endpoint 65 Staphylococcus aureus Immune Globulin 65 Initiates Phase III 65 introduced NEUGENE 65 oncolytic virus therapies 65 Presents Positive 65 Receives Milestone Payment 64 acetonide FA 64 Nucleic Acid Detection Immunoassay 64 By JAMAAL ABDUL 64 Vitrasert R 64 Rigel R# 64 Gets FDA Clearance 64 Anthrax Toxin 64 ALN PCS 64 CRMD# 64 Begins Dosing 64 Initiates Clinical 64 TAXUS Element Stent System 64 Phase 2b Clinical Trial 64 Pivotal Study 64 lucinactant 64 Endologix Powerlink System 64 miRview TM mets 64 Phase 1b clinical trials 64 ALTROPANE R 64 PI3K/Akt pathway inhibitor 64 Phase 1b Clinical Trial 64 Microwave Ablation System 64 Genasense ® oblimersen 64 Hedgehog Pathway Inhibitor 64 PF # [002] 64 tranquilizers diazepam 64 Shows Promise Against 64 Augment TM 64 Optical Biopsy System 64 platform HDL Mimetic 64 Prolongs Survival 64 Dupuytren Disease 64 LungExpress Dx TM 64 serine protease inhibitor CU# 64 Meets Primary Endpoint 64 non nucleoside inhibitor 64 SinuNase ™ 64 AKIP ™ 64 implantable VeriChip TM 64 equine osteoarthritis marketed 64 Pivotal Trial 64 Epigenomics proprietary 64 Therapeutic Competitors Companies 64 evaluating picoplatin 64 TAXUS Element Paclitaxel Eluting 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 virus HCV protease inhibitor 64 Augment ™ 64 markets HP Acthar 64 ENLIGHT 64 candidate XP# 64 recombinant PSMA vaccine 64 sarcoma melanoma 64 RNAi Therapeutic 64 eTag assays 64 R lenalidomide 64 HCV NS5B polymerase 64 Phase III Pivotal 63 Elagolix 63 Xcytrin R 63 International SMI SYNN 63 NASH Huntington 63 Announces Tentative Approval 63 FDA Clears 63 Oncotype DX colon cancer 63 Panzem R 63 DG# compounds targeting 63 evaluating T DM1 63 NDA Submission 63 MKC# MKC# PP 63 oral proteasome inhibitor 63 mSEPT9 63 Mylan Receives Approval 63 INSPIRE Trial Phase III 63 MEK Inhibitor 63 molecular imaging radiopharmaceuticals 63 Immunotherapeutic 63 subsidiaries visit http:/www.apricusbio.com 63 topically applied SEPA 63 Bayer HealthCare Onyx Pharmaceuticals 63 MelaFind ® 63 Phase III Clinical Trial 63 Presents Preclinical 63 GTC recombinant form 63 recurrent metastatic ovarian cancer 63 mertansine 63 mesylate tablets approved 63 Submits IND 63 Glufosfamide 63 IL# PE#QQR 63 PNP inhibitor 63 novel histone deacetylase 63 coronary stent merged 63 Announces Poster Presentations 63 Gentamicin Surgical Implant 63 tests miRview TM 63 miRview meso 63 ELADUR TM 63 RIGScan ™ 63 HDAC Inhibitor 63 selectively inhibit replication 63 Kinase Inhibitor 63 refractory chronic lymphocytic 63 Selective Electrochemical Tumor Ablation 63 HuMax TAC 63 AEG# 63 Tezampanel 63 adjuvant GIST 63 dasatinib Sprycel ® 63 novel therapeutic antibodies 63 Licenses Novel 63 apricitabine ATC 63 TO REQUIRE 63 Myocet 63 Hexvix ® 63 Successfully Completes Phase 63 Nanobody R 63 OMNARIS HFA 63 Solazed TM 63 product candidate Lpathomab 63 Entereg R 63 Besivance 63 CD# CEA 63 miconazole Lauriad R 63 RAS MAPK pathway 63 methylnaltrexone bromide 63 Ceflatonin R 63 NuroPro R 63 Fx #A 63 Phase 2b Trial 63 malignant mesothelioma Alfacell 63 supplemental biologics 63 progressive metastatic prostate 63 molecular imaging radiopharmaceutical 63 Locteron exclusively 63 Genotyping Test 63 Receives Fast Track 63 read Palintologist 63 Fludara ® 63 STRIKE PRICE COMPARES TO 63 Vascugel 63 Oracea R 63 FDA APPROVES 63 Submits Supplemental 63 IND Filing 63 Novel Oral 62 Intravenous Human 62 Evoltra ® 62 Septin9 62 Biomerix Corporation 62 benign prostatic hyperplasia enlarged 62 tramiprosate Alzhemed TM 62 NEBIDO VANTAS SUPPRELIN LA 62 PROVENGE ® 62 small molecule Hedgehog 62 Bazedoxifene 62 Phase #b/#a clinical 62 treat chronic sinusitis 62 var arrContent = 62 FDA Approves Novel 62 Initiates Clinical Trials 62 Abstract Accepted 62 Aeolus Pharmaceuticals Announces 62 blood serum biomarkers 62 miRview TM 62 BRILINTA 62 product Abreva ® 62 Septin 9 62 Lymphoseek ® 62 LymphoStat B TM 62 targeted radiotherapeutic 62 Maven Semantic 62 platinum chemotherapeutic 62 First Patient Enrolled 62 investigational humanized monoclonal antibody 62 FDA Accepts 62 OTCBB QTXB 62 SOLTAMOX TM tamoxifen citrate 62 structure infections ABSSSI 62 delivery polymer matrix 62 MCSP respectively 62 manufactures minimally invasive 62 deCODE ProstateCancer TM 62 Mg Usa 62 Lenocta TM 62 VitiGam 62 Endotoxin Activity Assay 62 Pivotal Phase III 62 sirtuin modulators 62 fusion enhancers 62 catheter occlusion 62 VIVITROL ® 62 NEBIDO R 62 Premarket Approval PMA 62 metastatic pancreatic 62 R Saizen R 62 metastatic colorectal 62 Demonstrates Significant 62 Tyrosine Kinase Inhibitor 62 Activity Assay 62 Pruvel TM 62 Drug Eluting Stent System 62 Inc. AMEX YMI 62 agonistic human 62 novel VDA molecule 62 miRview mets 62 Receives Orphan Drug 62 including Mitochondrial Disorders 62 BY WILLA J. 62 Vicriviroc 62 P#X# antagonist 62 PrevOnco 62 gastro intestinal inflammation 62 include Alferon N 62 qualitative serum 62 pharmacogenomic translational research 62 Testosterone MDTS ® 62 proprietary radiolabeled monoclonal 62 Cervista HPV HR 62 THR beta agonist 62 metastatic androgen independent 62 Vitamin D analogue 62 PDX pralatrexate 62 Files Investigational 62 Launches Generic Version 62 anti botulism antibody 62 Perflubutane Polymer Microspheres 62 Hsp# Inhibitor 62 Oral Fingolimod 62 lead Aganocide compound 62 Hepatocellular Carcinoma HCC 62 Kamada AAT 62 erlotinib Tarceva ® 62 vaginal lidocaine product 62 PD2i Analyzer 62 Cobalamin TM mediated 62 Neulasta R 62 Epidermal Growth Factor Receptor 62 IAP inhibitor 62 targeting miR 62 Alfacell proprietary ribonuclease 62 IMiDs ® 62 initiated Phase Ib 62 Generx TM 62 BHT DNA 62 CCR9 antagonist 62 dasatinib Sprycel 62 Empatic ™ 62 product Abreva 62 AAG geldanamycin analog 62 FACTIVE R gemifloxacin 62 StaphVAX R 62 OMAPRO ™ 62 FDA Approvable Letter 62 Outpatient Setting 62 NasdaqGM NTEC today 62 DNAwithPap TM Test 62 endoluminal stent graft 62 Nicotine Vaccine 62 Randomized Clinical Trials 62 IQ OQ PQ 62 highly purified pasteurized 62 Molecular Diagnostic Test 62 BCG refractory carcinoma 62 Arno Therapeutics 62 product Abreva R 62 Liprotamase 62 Marketing Approval PMA 62 Advanced Melanoma 62 HuMax Wnt 62 LEVADEX ™ 62 OTCBB PWRM.OB 62 oral nucleoside analogue 62 Deforolimus 62 OLpur TM H2H 62 immunotherapeutic vaccine 61 MKC# MT 61 Study Evaluating 61 EGFr expressing metastatic colorectal 61 Pegloticase 61 registrational Phase 61 PREVU i 61 Submits Investigational 61 phase IIb clinical 61 MT#/MEDI-# 61 Silodosin 61 Exherin 61 k Premarket Notification 61 metabolism viral replication 61 autologous cellular immunotherapy 61 Ozarelix 61 TFChem licenses 61 Zemiva TM 61 Nasdaq VNDA 61 About Positron Positron 61 candidates Augment ™ 61 Zemiva ™ 61 Phase Ib II 61 optical biosensors 61 David Rapperport Quest 61 IND Investigational New 61 cervix colon 61 nasal decolonization 61 EVLT R procedure 61 Initiate Phase 61 Kit CD# positive 61 Degarelix 61 Kosan dependence 61 GATTEX TM 61 brand ciclesonide HFA 61 phase IIb study 61 Iluvien ® 61 Aloprim TM allopurinol sodium 61 vaginally administered lidocaine 61 Septin9 biomarker 61 Illusionist Toy Story 61 octreotide implant 61 TKB# 61 Neutrolin ® 61 treat lupus renal 61 SCIB1 61 BUPHENYL R 61 Completes Patient Enrolment 61 Valortim TM 61 Safinamide 61 Pralatrexate 61 Presents Preclinical Data 61 QUADRAMET R 61 rALLy clinical trial 61 anti CD3 monoclonal 61 Bucindolol 61 IMiDs 61 Clinical Trial Results 61 Tr DNA 61 MAGE A3 ASCI 61 MSCRAMM ® 61 Hepatitis C Virus HCV 61 Antibody Drug Conjugate 61 pan histone deacetylase 61 RNAi Therapeutics 61 Nasdaq HALO biopharmaceutical 61 aerosolized AAT 61 albiglutide 61 OvaRex ® MAb 61 Plaque Psoriasis 61 Alferon LDO 61 AcryMed technologies 61 STEDESA 61 Teasing caresses 61 inhibit oxidative stress 61 hygienic cleansing 61 MassARRAY ® 61 DIFICID ™ 61 Solazed ™ 61 antibiotic candidate Ramoplanin 61 Taglich Brothers Initiates Coverage 61 IMA# 61 Biomarker Study 61 leading oral taxane 61 sandwiches cole slaw 61 multi kinase inhibitor 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 Anti CD# Antibody 61 RANK Ligand inhibitor 61 Receives Tentative Approval 61 Western Blotting 61 Pirfenidone 61 BEMA Granisetron 61 Dalbavancin 61 IgG1 monoclonal antibody 61 drug GAP #B# 61 Regenerative Cells 61 Serostim ® 61 OTCQX QRXPY 61 CCR5 mAb 61 molecular diagnostic assay 61 Archexin 61 vaginal candidiasis 61 mTOR kinase 61 ZEVALIN ® 61 LHRH antagonist 61 Aflibercept 61 Investigational Oral 61 #L Sterilizer 61 initiate multicenter 61 Survivin antagonist 61 alpha#beta# integrin 61 BioGlue ® 61 SoftScan R 61 molecular imaging pharmaceuticals 61 assigned PDUFA 61 Budesonide foam crofelemer 61 ASONEP TM 61 aldehyde dehydrogenase ALDH2 deficiency 61 Teva Provides Update 61 var arrUrl = 61 OncoVex 61 Stab stab 61 Phase 2a Clinical Trial 61 JOULFERON 61 Locked Nucleic Acid 61 Chrysalin r rusalatide acetate 61 BENLYSTA ® 61 First Patient Treated 61 assessing T DM1 61 Amigal TM 61 ONSOLIS TM 61 R#/MEM 61 receptor tyrosine kinase inhibitor 61 LymphoStat B belimumab 61 Civacir 61 Daclizumab 61 PREOS R 61 Drug Shows Promise 61 HGS ETR1 mapatumumab 61 VISICOL R 61 ALN HTT 61 BrachySil TM 61 Company Nasdaq RGDX 61 monoclonal antibody IgG1 Mab 61 Provectus Pharmaceuticals specializes 61 Denufosol 61 endometriosis ovarian cysts 61 Lung Cancer Drug 61 CINtec R 61 Glaucoma Treatment 61 Phase Ib IIa 61 Nabi HB Intravenous 61 Pathogen Detection 61 OTCBB PYTO 61 RECOTHROM ® 61 XYOTAX TM 61 Drug Candidate 61 INS# [001] 61 Zenvia ™ 61 By ANDREW LOGUE 61 zileuton CR 61 BLP# Liposome Vaccine 61 TNFerade TM 61 PDE4 inhibitor 61 IMiDs R 61 immunotherapeutic approaches 61 Luveniq 61 modified glutathione analog 61 Inc. Nasdaq VNDA 61 diagnostic radiopharmaceutical 61 Prodarsan 61 ocular formulation 61 NicVAX TM 61 Predictive medicine 61 Hormone Refractory Prostate Cancer 61 testosterone gel LibiGel 60 SEQureDx TM 60 Horizant ™ 60 verdict elicited gasps 60 eye socket ruptured 60 FDA Approvals 60 Onko Sure TM 60 Vascular Disrupting Agent 60 RECOTHROM R 60 targeted anticancer biopharmaceuticals 60 lung esophageal 60 Anturol TM 60 HDL Selective Delipidation 60 EVIZON TM 60 brivanib 60 Albuferon albinterferon alfa 2b 60 Phase 2a Trial 60 Zorbtive TM 60 Epi proColon 60 BioSante Pharmaceuticals Announces 60 proprietary capillary aerosolization 60 Européenne Mark 60 CTAP# Capsules 60 lintuzumab SGN 60 novel immunotherapies 60 Homspera TM 60 recombinant biopharmaceutical 60 multicenter Phase III 60 EMPOWER ™ 60 rumpled dresser 60 adrenergic regulation 60 histone deacetylase inhibitor 60 liver colon rectal 60 LEUKINE 60 histone deacetylase HDAC 60 P2V TM 60 Viral Immunotherapy platform 60 DNA RNA Medicines 60 Sapacitabine 60 highly selective inhibitor 60 hypervascular tumors 60 GTC recombinant human 60 Cancer Incidence Mortality 60 GATTEX ® 60 Rosetta Genomics microRNA 60 rxRNA 60 memantine HCl 60 fosbretabulin 60 BLA submission 60 sorafenib tablets 60 Hematological Malignancies 60 SUCCEED trial 60 IONSYS TM 60 Ceflatonin ® 60 NYSE Amex PTN 60 Alvine Pharmaceuticals 60 Opterone R 60 carcinoma mCRC 60 Nasdaq HALO 60 acyclovir Lauriad R 60 Demonstrates Positive 60 Pivotal Phase 60 Enzyme Replacement Therapy 60 Resurgex Plus R 60 OLIGON technology 60 TransVax TM 60 Bioral Amphotericin B 60 Initiate Clinical Trial 60 Exherin TM 60 Bosutinib 60 Staphylococcus aureus Polysaccharide Conjugate 60 Cerebril TM 60 5 lipoxygenase inhibitor 60 Presents Positive Preclinical 60 selective immunoproteasome inhibitor 60 Factor VIIa 60 SinuNase TM 60 Orapred ODT 60 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 60 sodium Injection 60 Dose Ranging Study 60 Tesmilifene 60 next generation URAT1 60 hyperphenylalaninemia HPA due 60 Power3 Alzheimer disease 60 Sanvar R 60 please visit www.metabolon.com 60 LifeVantage Announces 60 biomarkers predictive 60 sumatriptan DosePro 60 NasdaqGM SPPI 60 UroVysion 60 BLA filing 60 DRUG ADMINISTRATION 60 LibiGel ® 60 Emily Blunt shimmered 60 targeted immunotherapies 60 PrevOnco ™ 60 Therapy RecoveryRx TM 60 Allovectin 7 r 60 overactive bladder VANTAS R 60 superparamagnetic iron oxide nanoparticles 60 OTC BB PVCT 60 proprietary PEGylation 60 acadesine 60 IND Application 60 visit http:/www.neogenomics.org 60 HCV polymerase 60 Nasdaq PGNX today 60 ImmuKnow R 60 molecular chaperone regulation 60 boxer dachshund bulldog 60 Therapeutic Vaccine 60 developing calcitonin 60 Fast Track Status 60 Thrombin topical Recombinant 60 drug pipeline TAFA# 60 immunosuppressive compound 60 IMiDs ® compound 60 Exelixis compounds 60 candidate AQ4N 60 use neuroblocking technology 60 Phase Ib clinical trials 60 oral Janus kinase 60 Phase III Clinical Trials 60 Phase III PREGNANT PROCHIEVE 60 Glycopyrrolate 60 Telik Announces 60 ADP receptor antagonist 60 Begins Shipment 60 Cerebral Amyloid Angiopathy 60 Temsirolimus 60 Phase III Trial 60 Systemic lupus erythematosus SLE 60 fluorinated carbohydrate mimics 60 hyaluronidase enzyme 60 REYNOLDS GALLERY 60 Evalve MitraClip R 60 Marketing Authorization Application 60 Phase IIb Trial 60 telomerase therapeutic 60 Pharmos pipeline 60 CTRC AACR 60 apoptosis inducer 60 include ClindaReach TM 60 acne impetigo 60 Skin Cholesterol Test 60 chronically immunosuppressed solid 60 commercialize CorMedix drug 60 biostatistical analysis 60 monitoring disposables endosurgery 60 Pafuramidine 60 See CLINICAL PHARMACOLOGY 60 myelodysplastic myeloproliferative diseases 60 include Altastaph TM 60 OTCBB URGP specialty 60 3hours #mins #.#secs M 60 glittering dupatta scarves 60 particularly SANCTURA XR 60 EOS NASDAQ MELA 60 Tutoplast Process R 60 J Antimicrob Chemother 60 leukotriene pathway 60 ALVESCO ® 60 MEK inhibitor 60 name Biospherics 60 Surfaxin LS 60 product Zingo TM 60 Synta Announces 60 psoriasis rheumatoid arthritis 60 myelofibrosis polycythemia vera 60 OMP #R# 60 miRview ™ mets 60 By QianMian #-#-# 60 selective A2A adenosine receptor 60 NUEDEXTA ™ 60 herpetic keratitis 60 investigational therapies 60 banned Darvon Darvocet 60 anticancer compound 60 Investigational Compound 60 MULLIGAN FAMILY FUN CENTER 60 Orphan Drug status 60 motexafin gadolinium Injection 60 Ercole Biotech 60 Ceragenin ™ 60 biologic therapeutics 60 Bafetinib 60 Clinical Trial Evaluating 60 Vicinium TM 60 rusalatide acetate 60 Investigational Device Exemption 60 Janis Joplin soundalike respiratory 60 STOP SHOPPING FOR 60 OTCBB IMUC 60 PHASE III 60 Gabriel Mollet 60 midstage trials 60 cathepsin K inhibitor 60 Breast Cancer Assay 60 Brussels THR 60 gefitinib Iressa 60 Randomized Double blind 60 SUMAVEL 60 5 HT3 antagonist 60 antiangiogenesis therapies 60 ThermoDox R 60 Psoriasis Drug 60 t2cure GmbH 60 MGd 60 pancreas esophagus 60 Tibotec Therapeutics division 60 Liberte TM 60 EVIZON TM squalamine lactate 60 VEGFR2 inhibitor 60 NAVISTAR R 60 NPM1 mutation 60 investigational HCV polymerase 60 candidate Trofex TM 60 RenaZorb TM 60 NADiA ProsVue 60 NuroPro ® 60 TNF Blockers 60 Small Molecule 60 NASDAQ CXSP announced 60 hepatitis C viral infection 60 Qutenza TM 60 Application BLA 60 Afatinib 60 Application MAA 60 Cotara ® 60 pharmacogenetic test 60 TNFerade ™ 60 TOCOSOL Camptothecin 60 Biologic License Application BLA 60 Phase III multicenter 60 MyVax R 60 Recombinant Human 60 Systemic Sclerosis 59 Ridaforolimus 59 topical non steroidal 59 Spiegelmer ® 59 Issued Patent 59 CYP#A# substrate 59 Myocardial Perfusion Imaging 59 product ColonSentry TM 59 romazarit 59 #/#/# Cytokinetics Incorporated 59 Ixempra 59 Present Preclinical Data 59 Junovan TM 59 diarrhea predominant irritable 59 MOVIPREP R 59 R#.# #x# R#.# 59 undergoing elective percutaneous 59 Metastatic Melanoma 59 CyPath R 59 mesylate tablets 59 Adenosine Therapeutics 59 Phase IIIb clinical 59 Commence Phase 59 cervical breast 59 Cellegesic 59 USP Tablets PEPCID 59 generation purine nucleoside 59 Vitrasert ® 59 Preclinical Study 59 Trobalt 59 hypoxia activated prodrug 59 please visit http:/www.sunesis.com 59 Aurora Kinase 59 commercialize ZYFLO CR 59 silicon carbide SiC gallium 59 bazedoxifene conjugated estrogens 59 OvaDx 59 treat dysmenorrhea 59 Pain Neutralizer holds 59 novel peptides 59 Quark Biotech 59 Lenocta 59 Inc. Nasdaq IMGN 59 See BioWorld Today 59 NeoBatch NeoSort 59 Phase IIb clinical trials 59 Muraglitazar 59 Intravitreal 59 XmAb ® 59 Sturckow eased 59 submitted Biologics License 59 Hematide ™ 59 Gamunex C 59 Cintredekin Besudotox 59 myocardial infarction ventricular fibrillation 59 IND submission 59 R bendamustine hydrochloride 59 visit www.regenbio.com 59 amplified nucleic acid 59 biomarker validation 59 TRO# 59 Dr. Gabriel Lasala 59 Neuromodulation System 59 HepeX B TM 59 Hepatitis C HCV 59 Rheumatoid Arthritis Drug 59 Initiates Phase 2b 59 toenail onychomycosis 59 Fireworks resounded 59 therapeutic monoclonal antibodies 59 HDL Mimetic Peptide 59 ICs lasers 59 phase III isavuconazole 59 ERYtech 59 NATIONAL ECONOMIC COUNCIL DIRECTOR 59 histone deacetylase HDAC inhibitor 59 PROVENGE sipuleucel T 59 Lupatech BMF & 59 Cand5 59 Warfarin Coumadin 59 Levoleucovorin 59 REVOLUTIONARY NEW 59 Vascular Closure Device 59 Preclinical Data 59 BioGlue R 59 wily bandit 59 antibody MAb 59 Romiplostim 59 Interferon Gamma 59 HIV maturation inhibition 59 ATryn ® GTC recombinant 59 Farfan Juan Pablo 59 www.ucb group.com 59 Other ImmunoGen collaborative 59 Affymetrix GeneChip ® 59 monoclonal antibody MAb 59 CINQUIL 59 Stieg Larsson Knopf FH 59 spillway diverts water 59 Taisho Pharmaceuticals 59 Ataluren 59 multicenter Phase II 59 vaccines oncolytic virus 59 Phase IIIb 59 BiovaxID TM 59 TRAIL receptor antibody mapatumumab 59 Milestone Payment 59 AE# vaccine 59 miconazole Lauriad ® 59 programs visit http:/www.bionovo.com 59 Apaziquone 59 delta opioid receptor 59 Eyvind Brynildsen Mitsubishi Lancer 59 cutaneous T 59 Cloretazine ® 59 Androxal TM 59 Clinical Trials Update 59 Fast Track designations 59 Squalamine 59 approved incretin mimetic 59 Onko Sure ™ 59 pain palliation 59 sulfonylhydrazine class 59 opioid induced bowel dysfunction 59 Naive Patients 59 Efficacy Results 59 tendon dislocated shoulder 59 CEQ# 59 Inc. ProMetic www.prometic.com 59 cyclobenzaprine hydrochloride extended 59 Traci Arbios 59 candidate epratuzumab 59 Preclinical Efficacy 59 Annamycin 59 Biological Therapy 59 developing Zerenex ferric 59 systemic anaplastic large 59 vivo fluorescence imaging 59 Distributors shunned 59 commercializing proteomics discoveries 59 Single Dose 59 CLIA laboratory 59 docetaxel Taxotere ® 59 Fibrin MB 59 Phase IIb III 59 Soliris eculizumab 59 milnacipran HCl 59 2 methoxyestradiol 59 storied chateau 59 IDI MRSA 59 Second Pivotal Phase 59 Pemphigus Vulgaris 59 submitted supplemental Biologics 59 sitaxsentan sodium 59 Angiocept 59 'S ABILITY TO 59 compound INCB# 59 Sestamibi 59 Phase 2a clinical trials 59 microsurgical disciplines 59 Fortical R 59 Taro Receives 59 Division Schweinfurt Germany 59 pelvic malignancies 59 investigational immunotherapy 59 FDA Orphan Drug 59 Investigational Device Exemption IDE 59 subsidiaries InnerCool Therapies 59 Nasdaq RGDX 59 candidates bavituximab 59 samarium Sm 59 Antisense Drug 59 polysaccharide polymer 59 DosePro TM 59 dependent kinase inhibitor 59 Nasdaq OMER 59 BRIM2 59 Phase IIb Clinical Trial 59 lavender headscarf 59 Aganocide ® 59 ViaCyte 59 REPRONEX R menotropins 59 ALK inhibitor 59 BrachySil 59 FullTerm 59 forodesine 59 CIP TRAMADOL ER 59 CHASKA Minn. YE Yang 59 Aganocide 59 Delipidation 59 STRIDE PD 59 rotavirus shingles 59 Pulse CO Oximetry Pulse 59 HQK 59 SitePoint Forum 59 NuroPro ® AD 59 Begin Clinical Trials 59 commercialize deforolimus 59 Nasdaq SPPI 59 CIMZIA r 59 Receive Milestone Payment 59 candidate NGX 59 CD# monoclonal antibody 59 Supplemental Biologics License Application 59 metabolomics driven 59 YONDELIS 59 Fibrin Patch 59 visit www.virtualscopics.com 59 Prodarsan ® 59 vitro diagnostic tests 59 Inflammatory Diseases 59 Enzastaurin 59 www.pranabio.com 59 dermatology therapies 59 IRX 2 59 exemption IDE 59 sapacitabine CYC# 59 factor VIIa 59 candidate TNFerade biologic 59 Aurexis 59 AFREZZA TM 59 Prognostic Value